3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
3
Completed
3
Terminated
2
Recruiting
2
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Sarcoma
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
CNS
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Osteosarcoma
1
Mouth Neoplasms
1
Interventions
Cisplatin
28
toripalimab
14
Radiotherapy
12
Gemcitabine
12
Capecitabine
11
Radiotherapy, Intensity-Modulated
10
pembrolizumab
9
Surgical Procedures, Operative
9
Docetaxel
9
tislelizumab
8
Carboplatin
7
Drug Therapy
6
Blood Specimen Collection
6
anlotinib
5
Taxes
5
Paclitaxel
5
Nivolumab
5
Fluorouracil
5
Cetuximab
5
130-nm albumin-bound paclitaxel
5
Thyroxine
4
Magnetic Resonance Spectroscopy
4
Cyclophosphamide
4
trametinib
3
sintilimab
3
camrelizumab
3
Radiation
3
Observation
3
Injections
3
Immune Checkpoint Inhibitors
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Positron Emission Tomography Computed Tomography
×
Head & Neck
×
Clear all
NCT06726512
2024-12-10
qMAP
University Medical Center Groningen
Phase NA
Not yet recruiting
30 enrolled